CLINICAL_TRIALS
trial_result
· 2009-11-26
Clinical Trial Update: Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding [Phase 3]
Summary
A Phase 3 trial of recombinant coagulation factor VIIa in patients with severe bleeding was terminated; results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Acquired Bleeding Disorder, Trauma | Phase 3 | Status: TERMINATED | Results posted: 2009-11-26